Drug X which inhibit the binding of RANKL to its receptor (RANK) in osteoporosis:
High-Yield Explanation
Ans. C. DenosumabOsteoclasts express RANK receptor which on stimulation causes resorption of bone. Denosumab is monoclonal antibody which inhibit the binding of ligand to the receptor and thus play a role in osteoporosis.